Trilexium (TRX-E-009-1) is a third-generation of benzopyran structurally related to TRX-E-002-1 (HY-114250). Trilexium increases p21 protein expression and induces apoptosis. Trilexium depolymerizes microtubules. Trilexium shows broad anti-cancer activity[1][2].
Molecular Weight:
426.43
Purity:
99.70
CAS Number:
[1983180-82-0]
Formula:
C24H23FO6
Target:
Apoptosis,Caspase,Microtubule/Tubulin,PARP
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
